CHCT vs NYC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

CHCT

39.1
AI Score
VS
It's a Tie!

NYC

39.1
AI Score

Investment Advisor Scores

CHCT

39score
Recommendation
AVOID NEW MONEY

NYC

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CHCT NYC Winner
Forward P/E 37.3134 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 7.4% -40.1% CHCT
Earnings Growth 119.1% 0.0% CHCT
Tradestie Score 39.1/100 39.1/100 Tie
Profit Margin 16.8% 38.9% NYC
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CHCT 1M: -9.2% · 3M: -30.9% NYC 1M: -0.7% · 3M: -28.9%

Current Technical Phase

CHCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.0%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $13.00

NYC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $5.93

Fundamentals Snapshot

Metric CHCT NYC
Market Cap — —
Forward P/E 37.3 0.0
Trailing P/E 19.0 1.2
Revenue (TTM) — —
Revenue Growth 0.1% -0.4%
Gross Margin 0.8% 0.2%
Operating Margin 0.3% -0.6%
EPS 0.68 4.90
Dividend Yield 0.14% —

Frequently Asked Questions

Based on our detailed analysis, CHCT and NYC are evenly matched. This is a close call that depends on your specific investment goals.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.